Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: Results from a German real‐world cohortFabian Jost‐Brinkmann, Raphael Mohr, Münevver Demir et al.|Alimentary Pharmacology & Therapeutics|2023Cited by 57
Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular CarcinomaRaphael Mohr, Christoph Roderburg, Fabian Jost‐Brinkmann et al.|Frontiers in Immunology|2021Cited by 33
High-Sensitivity Cardiac Troponin T in Patients with Severe Chronic Kidney Disease and Suspected Acute Coronary SyndromeBrunilda Alushi, Alexander Lauten, Fabian Jost‐Brinkmann et al.|Journal of Clinical Medicine|2021Cited by 8
High Sensitivity Cardiac Troponin T in Patients with Severe Chronic Kidney Disease and suspected Acute Coronary SyndromeBrunilda Alushi, Alexander Lauten, Salvatore Cassese et al.|Preprints.org|2021Cited by 6
P3182Diagnostic accuracy of high sensitive cardiac troponin T in patients with suspected acute coronary syndrome and severe chronic kidney diseaseBrunilda Alushi, Alexander Lauten, Fabian Jost‐Brinkmann et al.|European Heart Journal|2018Cited by 0